american

Frost & Sullivan: OptiSigns Receives the 2025 North American SMB Digital Signage Product Leadership Recognition for Excellence in Digital Transformation and Customer Engagement

OptiSigns recognized for redefining SMB digital signage through automation, flexibility, and enterprise-class performance. SAN ANTONIO, Nov. 12, 2025 /PRNewswire/ -- Frost…

3 weeks ago

Halia Therapeutics to Present Groundbreaking Data on Novel Allosteric NEK7 Inhibitor Ofirnoflast at the 2025 American Society of Hematology Annual Meeting

- Data demonstrates ofirnoflast's efficacy in myelodysplastic syndrome (MDS) with robust and sustained hematologic responses – - A novel mechanism…

3 weeks ago

Spectrum Business Receives Frost & Sullivan’s 2025 North American Competitive Strategy Leadership Recognition for Excellence in Dedicated Internet Access

Spectrum Business Leverages Digital Innovation and Customer-Centric Execution to Drive Strategic Excellence in Internet Access Services SAN ANTONIO, Nov. 10,…

3 weeks ago

George Medicines presents long-term efficacy and safety data for single pill triple combination therapy for hypertension at American Heart Associations Scientific Sessions 2025

London, UK, Boston, MA, 9 November 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs…

4 weeks ago

Medera Presents Late-Breaking Data from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at American Heart Association Scientific Sessions 2025

November 09, 2025 09:00 ET  | Source: Medera Inc. BOSTON, Nov. 09, 2025 (GLOBE NEWSWIRE) -- Medera Inc. ("Medera"), a…

4 weeks ago

Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025

THE WOODLANDS, Texas, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that new sotagliflozin clinical…

4 weeks ago

Data for Lorundrostat in Chronic Kidney Disease and Hypertension Presented at American Society of Nephrology (ASN) Kidney Week 2025

– Late-breaking presentation of Explore-CKD trial at ASN Kidney Week – – Pivotal Phase 3 Launch-HTN trial featured in the…

4 weeks ago

e-Contact Receives Frost & Sullivan’s 2025 Latin American Contact Center Solutions Customer Value Leadership Recognition for Excellence in Innovation and Customer Engagement

e-Contact is honored for delivering cost-effective, AI-driven solutions that empower clients and transform customer engagement across Latin America SAN ANTONIO,…

4 weeks ago

Andor Health’s Agentic AI Platform, ThinkAndor, Receives Frost & Sullivan’s 2025 North American Transformational Innovation Leadership Recognition for Excellence in Acute Care Virtual Health

Recognized for its transformational innovation and customer impact in driving the evolution of acute care virtual health through advanced, agentic…

4 weeks ago

Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

November 03, 2025 16:45 ET  | Source: Fulcrum Therapeutics, Inc. ― Pociredir Phase 1b PIONEER Trial Data in Sickle Cell…

1 month ago